In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: A Spanish multicenter study

Journal of Chemotherapy

Volumn 9, Issue 6, 1997, Pages 394-402

  Garcia Rodriguez, J A ^a,g   Martin, Trujillano ^a,b   Baquero, F ^c   Cisterna, R ^d   Gobernado, M ^a,e   Linares, F ^f   Martin Luengo, F ^a   Piedrola G ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e UNIVERSITY OF MURCIA   (Spain)

^f UNIVERSITY OF GRANADA   (Spain)

^g Hospital Univcrsitario   (Spain)

Author keywords

Fosfomycin trometamol; Urinary tract infections (UTIs)

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFIXIME; CEFUROXIME; COTRIMOXAZOLE; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; NALIDIXIC ACID; NORFLOXACIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SENSITIVITY; ENTEROBACTER; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 0031464791     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.6.394     Document Type: Article

References (16)

1. Bergan T. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Infection 1990; 18 (Suppl. 2): S75-S76.
2. Ferrari V, Bonanomi L, Borgia M, Lodola E, Marca GA. A new fosfomycin derivative with much improved bioavailability by oral route. Chemioterapia 1981; 4: 59-63.
3. Säbada B, Löpez de Ocariz A, Dios C, Fos D, Azanza JR, Honorato J. Concentraciones urinarias de fosfomicina tras la administraciön de una dosis ünica de fosfomicina trometamol: Aplicaciôn a la terapia monodosis de las infecciones urinarias. Rev Esp Quimioterap 1995; 8: 229-32.
4. Pavesio D, Pecco P, Bianchi E, Segre G. Pharmacokinetics in children of a new fosfomycin derivative with improved bioavailability. In: Récents Advances in Chemotherapy. Proceedings of the 14th International Congress of Chemotherapy (Kyoto, 1985). Antimicrobial Section 3. Tokyo: Tokyo University Press, 1986; 1911-1912.
5. Segre G, Bianchi E, Cataldi A, Zannini G. Pharmacokinetic profile of fosfomycin trometamol. Eur Urol 1987; 13 (Suppl. 1): 56-63.
6. Wilson P, Williams JD, Ronaldi E. Comparative pharmacokinetics of fosfomycin trometamol, sodium fosfomycin and calcium fosfomycin in humans. In: New Trends in Urinary Tract Infections, Neu HC, Williams JD (Eds.), Basel: Karger, 1988: 136-42.
7. Boerema JBJ. Fosfomycin trometamol in a single dose versus norfloxacin for seven days in the treatment of uncomplicated urinary infections in general practice. Infection 1990; 18 (Suppl. 2): S80-S88.
8. Corbusier A, Germeau F, Bonadio M. Fosfomycin trometamol versus amoxycillin single-dose therapy. In: New Trends in Urinary Tract Infections, Neu HC, Williams JD (Eds.), Basel: Karger, 1988: 185-90.
9. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobicaly, 2nd Ed. Approved Standard. M7-A2. NCCLS, Villanova, Pa. 1990.
10. Andrews JM, Baquero F, Beltran JM, Canton E, Crokaert F, Gobernado M. International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother 1983; 12: 357-61.-
11. Barry AL, Fuchs PC. In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrob Agents Chemother 1991; 35: 1235-8.
12. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing. M100-S4. NCCLS, Villanova, Pa. 1992.
13. Forsgren A, Walder M. Antimicrobial activity of fosfomycin in vitro. J Antimicrob Chemother 1983; 11: 467-71.
14. Greeenwood D, Coyle A, Andrew J. The trometamol salt of fosfomycin: microbiological evaluation. Eur Urol 1987; 13 (Suppl. 1): 69-75.
15. King A, Phillips I. Comparative in vitro activity of fosfomycin trometamol against urinary tract pathogens. In: New Trends in Urinary Tract Infections, Neu HC, Williams JD (Eds.), Basel: Karger, 1988: 242-9.
16. Wise R, Andrews JM. Fosfomycin trometamol: an in vitro study. In: New Trends in Urinary Tract Infections, Neu HC, Williams JD (Eds.), Basel: Karger, 1988: 232-41.